Auriga Laboratories Private Limited
About Auriga Laboratories Private Limited
Data last updated:
Auriga Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC280787. Its GSTIN is 10AANCA6192P1Z8 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Swati Saran and Abhishek Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wa – 107 Old Plot – 22 Shakarpur, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹97.25 Lakh, a growth of 62% compared to the previous year. For the same year it recorded a net profit of ₹86,267 (net margin 0.9%) and EBITDA of ₹1.31 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 40% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressWa – 107 Old Plot – 22 Shakarpur, Delhi, India – 110092
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Auriga Laboratories Private Limited
The main business activity of Auriga Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Auriga Laboratories Private Limited FY 2025 filings available
Auriga Laboratories Private Limited reported revenue of ₹97.25 Lakh (up 62% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Auriga Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 62% growth in the latest year. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Auriga Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.31 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹86,267 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Auriga Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Auriga Laboratories are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Auriga Laboratories Private Limited
Auriga Laboratories Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Janricsan Pharma Private Limited | ₹97.47 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Thiruvananthapuram, Kerala, India |
| Muktha Laboratories Private Limited | ₹97.42 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Chennai, Tamil Nadu, India |
| Krishna Green Crops Private Limited | ₹97.35 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Indore, Madhya Pradesh, India |
| Manushyaa Blossom Private Limited | ₹97.33 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Puducherry, India |
| Miracle Pesticides Private Limited | ₹97.31 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Ahmedabad, Gujarat, India |
| Auriga Laboratories Private Limited this company | ₹97.25 Lakh (FY 2024) | •••• | •••• | 62.0% | •••• | Delhi, India |
| Umr Laboratories Private Limited | ₹97.2 Lakh (FY 2025) | •••• | •••• | 67.0% | •••• | Hyderabad, Telangana, India |
| Aquasis Water Treatment Technologies Private Limited | ₹97.16 Lakh (FY 2023) | •••• | •••• | 14.0% | •••• | Neyyattinkara, Kerala, India |
| Mitawa Calcium and Minerals Private Limited | ₹97.11 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Jodhpur, Rajasthan, India |
| Malda Container Industries Private Limited | ₹96.91 Lakh (FY 2023) | •••• | •••• | •••• | Malda, West Bengal, India | |
| Sainbaxy Labs Private Limited | ₹96.88 Lakh (FY 2025) | •••• | •••• | 116.0% | •••• | Kochi, Kerala, India |
Peers are the five companies nearest above and the five nearest below Auriga Laboratories by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Auriga Laboratories Private Limited
Auriga Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swati Saran | Director | 26 May 2015 | 11 Years 4 Months | Current |
| Abhishek Kumar | Director | 31 Aug 2021 | 5 Years 1 Months | Current |
Ownership and Shareholding of Auriga Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Auriga Laboratories Private Limited
Auriga Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Auriga Laboratories Private Limited
Employment history and EPFO contributions of people linked to Auriga Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Auriga Laboratories Private Limited
Auriga Laboratories Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Abhishek Kumar was appointed as Director on 31 Aug 2021.
Credit Ratings, Litigation & Regulatory Alerts for Auriga Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Auriga Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Auriga Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Auriga Laboratories Private Limited
Auriga Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AANCA6192P1Z8 | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Auriga Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Auriga Laboratories Private Limited
Auriga Laboratories is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 May 2015 (11+ years old) and is registered under CIN U24100DL2015PTC280787.
Auriga Laboratories reported revenue of ₹97.25 Lakh for FY 2024 (up 62% YoY).
Auriga Laboratories has 2 current directors:
- Swati Saran - Director
- Abhishek Kumar - Director
Auriga Laboratories reported a net profit of ₹86,267 (net margin 0.9%) and EBITDA of ₹1.31 Lakh (EBITDA margin 1.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Auriga Laboratories is 52% over three years and 40% over five years. In the latest year (FY 2024) revenue rose 62%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Auriga Laboratories is 10AANCA6192P1Z8, registered in Bihar.
The CIN (Corporate Identification Number) of Auriga Laboratories is U24100DL2015PTC280787. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Auriga Laboratories was incorporated on 26 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Auriga Laboratories by revenue are Janricsan Pharma Private Limited, Muktha Laboratories Private Limited, Krishna Green Crops Private Limited, Manushyaa Blossom Private Limited, Miracle Pesticides Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Abhishek Kumar was appointed as Director on 31 Aug 2021. Sangita Kumari ceased to be Director on 31 Aug 2021. Sangita Kumari was appointed as Director on 26 May 2015. Auriga Laboratories has 4 board changes on record in total.
The registered office of Auriga Laboratories is at Wa – 107 Old Plot – 22 Shakarpur, Delhi, India – 110092.